| scholarly article | Q13442814 |
| P50 | author | Olaf Utermöhlen | Q41603860 |
| P2093 | author name string | Wolfgang Deppert | |
| Michael Bruns | |||
| Jara Wanger | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
| Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus | Q28291275 | ||
| Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
| Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. | Q33815865 | ||
| Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells | Q33848587 | ||
| Redefining chronic viral infection | Q34018497 | ||
| Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis | Q34699212 | ||
| Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients | Q35698637 | ||
| Emergence of virus escape mutants after immunization with epitope vaccine. | Q35851158 | ||
| MENINGITIS IN MAN CAUSED BY A FILTERABLE VIRUS : II. IDENTIFICATION OF THE ETIOLOGICAL AGENT | Q36256814 | ||
| Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy | Q36380506 | ||
| Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes | Q37876227 | ||
| Evolving role of tumor antigens for future melanoma therapies. | Q38232855 | ||
| Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination | Q38934976 | ||
| Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice | Q38959098 | ||
| Transcription factors link mouse WAP-T mammary tumors with human breast cancer | Q39242906 | ||
| Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression | Q39294303 | ||
| Simian virus 40 specific proteins on surface of HeLa cells infected with adenovirus 2–SV40 hybrid virus Ad2+ND2 | Q39530403 | ||
| Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. | Q41484051 | ||
| Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes | Q41544986 | ||
| Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis | Q43794889 | ||
| Cell and molecular biology of simian virus 40: implications for human infections and disease | Q44314704 | ||
| Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates | Q45388711 | ||
| Host cell-dependent homologous interference in lymphocytic choriomeningitis virus infection | Q45831859 | ||
| Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein | Q45847345 | ||
| Virus-specific delayed-type hypersensitivity (DTH). Cells mediating lymphocytic choriomeningitis virus-specific DTH reaction in mice | Q45853632 | ||
| Entry of antivirally active T lymphocytes into the thymus of virus-infected mice | Q45854383 | ||
| CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis | Q46209513 | ||
| Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs | Q47701358 | ||
| T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? | Q50778923 | ||
| T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. | Q50902062 | ||
| Expression of a whey acidic protein transgene during mammary development. Evidence for different mechanisms of regulation during pregnancy and lactation. | Q52237167 | ||
| SV-40 INDUCED PROLIFERATION OF TISSUE CULTURE CELLS OF RABBIT, MOUSE, AND PORCINE ORIGIN. | Q53437014 | ||
| Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo | Q59082223 | ||
| A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland | Q73540266 | ||
| Requirements for growth of single human cells | Q78532441 | ||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 38487-38503 | |
| P577 | publication date | 2015-10-19 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses | |
| P478 | volume | 6 |
| Q92557659 | Association Between Simian Virus 40 and Human Tumors |
| Q40027037 | Cancer immunotherapy: weak beats strong |
| Q26745442 | Checkpoint Inhibitors and Their Application in Breast Cancer |
| Q41924363 | Immunotherapy of WAP-TNP mice with early stage mammary gland tumors |
| Q37662081 | T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy. |
Search more.